5.22% volatility in Accolade Inc (ACCD) last month: This is a red flag warning

Accolade Inc (NASDAQ: ACCD) on Tuesday, soared 3.25% from the previous trading day, before settling in for the closing price of $3.38. Within the past 52 weeks, ACCD’s price has moved between $3.08 and $15.36.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 36.31%. The company achieved an average annual earnings per share of 27.94%. With a float of $69.18 million, this company’s outstanding shares have now reached $78.07 million.

The extent of productivity of a business whose workforce counts for 2400 workers is very important to gauge. In terms of profitability, gross margin is 43.1%, operating margin of -21.28%, and the pretax margin is -17.76%.

Accolade Inc (ACCD) Insider Updates

Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of Accolade Inc is 14.10%, while institutional ownership is 73.68%. The most recent insider transaction that took place on Nov 19 ’24, was worth 515. Before that another transaction happened on Nov 19 ’24, when Company’s Officer proposed sale 380 for $3.34, making the entire transaction worth $1,271.

Accolade Inc (ACCD) Performance Highlights and Predictions

As on 8/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.07 earnings per share (EPS) for the period topping the consensus outlook (set at -0.23) by 0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.21 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 27.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.90% during the next five years compared to -2.85% drop over the previous five years of trading.

Accolade Inc (NASDAQ: ACCD) Trading Performance Indicators

Accolade Inc (ACCD) is currently performing well based on its current performance indicators. A quick ratio of 2.68 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.64.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -0.87 in one year’s time.

Technical Analysis of Accolade Inc (ACCD)

The latest stats from [Accolade Inc, ACCD] show that its last 5-days average volume of 1.23 million was superior to 1.09 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 35.62%. Additionally, its Average True Range was 0.19.

During the past 100 days, Accolade Inc’s (ACCD) raw stochastic average was set at 27.89%, which indicates a significant decrease from 56.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.27% in the past 14 days, which was lower than the 58.17% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.67, while its 200-day Moving Average is $6.26. Now, the first resistance to watch is $3.57. This is followed by the second major resistance level at $3.66. The third major resistance level sits at $3.78. If the price goes on to break the first support level at $3.36, it is likely to go to the next support level at $3.24. Assuming the price breaks the second support level, the third support level stands at $3.15.

Accolade Inc (NASDAQ: ACCD) Key Stats

Market capitalization of the company is 281.08 million based on 80,537K outstanding shares. Right now, sales total 414,290 K and income totals -99,810 K. The company made 106,360 K in profit during its latest quarter, and -23,930 K in sales during its previous quarter.